These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Alterations in prednisolone disposition as a result of oral contraceptive use and dose. Meffin PJ; Wing LM; Sallustio BC; Brooks PM Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464 [TBL] [Abstract][Full Text] [Related]
9. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. Lidegaard O BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470 [TBL] [Abstract][Full Text] [Related]
10. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030 [TBL] [Abstract][Full Text] [Related]
11. [Metamizol-caffeine elimination in females with increased serum aminotransferase activities treated with steroidal oral contraceptives]. Bergmann M; Splinter FC; Henschel L; Balogh A; Hoffmann A; Klinger G Dtsch Z Verdau Stoffwechselkr; 1988; 48(5):261-7. PubMed ID: 3150832 [TBL] [Abstract][Full Text] [Related]
12. Effects of tobacco smoking and oral contraceptive use on theophylline disposition. Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419 [TBL] [Abstract][Full Text] [Related]
13. Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids. Rietveld EC; Broekman MM; Houben JJ; Eskes TK; van Rossum JM Eur J Clin Pharmacol; 1984; 26(3):371-3. PubMed ID: 6734698 [TBL] [Abstract][Full Text] [Related]
15. Increased metabolic clearance of acetaminophen with oral contraceptive use. Abernethy DR; Divoll M; Ochs HR; Ameer B; Greenblatt DJ Obstet Gynecol; 1982 Sep; 60(3):338-41. PubMed ID: 6897933 [TBL] [Abstract][Full Text] [Related]
16. Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon. Mönig H; Baese C; Heidemann HT; Ohnhaus EE; Schulte HM Br J Clin Pharmacol; 1990 Jul; 30(1):115-8. PubMed ID: 2390422 [TBL] [Abstract][Full Text] [Related]
17. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data. Mann JI Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056 [TBL] [Abstract][Full Text] [Related]
18. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids. Chambers DM; Jefferson GC; Chambers M; Loudon NB Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420 [TBL] [Abstract][Full Text] [Related]
19. Influence of oral contraceptives on drug therapy. Teichmann AT Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2208-13. PubMed ID: 2256528 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of oral contraceptives and cardiovascular disease. Chasan-Taber L; Stampfer MJ Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]